Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: October 29, 2024
Reporting Period: Fiscal First Quarter ended September 30, 2024
Context: The Company issued a press release announcing preliminary unaudited revenue results for the quarter. The Company is an emerging growth company.
Key Financial Metrics
The filing text references the announcement of preliminary unaudited revenue results but does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within the body of this 8-K document. These figures are contained in the attached press release (Exhibit 99.1), which is not included in the provided text.
Material Changes
The filing does not contain specific data to compare current period results against prior comparable periods. It serves solely as a notification that preliminary results have been issued.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release regarding Q1 2024 revenue but does not include forward-looking guidance or detailed management commentary in the text provided.
Risks and Contingencies: The filing includes a standard disclaimer stating that the information is not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific preliminary revenue figures for the quarter ended September 30, 2024.
- Verify the unaudited nature of the reported results as stated in the filing.
- Check subsequent filings for the full audited financial statements to confirm the preliminary data.
- Confirm the Company's status as an emerging growth company and any associated reporting exemptions.